C-terminal truncation of CXCL10 attenuates inflammatory activity but retains angiostatic properties
L. Dillemans, K. Yu, A. De Zutter, S. Noppen, M. Gouwy, N. Berghmans, M. De Bondt, L. Vanbrabant, S. Brusselmans, E. Martens, D. Schols, P. E. Marques, S. Struyf, P. Proost
This study shows that truncating the C-terminus of CXCL10 reduces its inflammatory activity but maintains its anti-angiogenic effects.
bioRxiv · Jul 10, 2023 · PreprintImmunology